We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$4.45B
AUM Growth
+$175M
Cap. Flow
-$73.9M
Cap. Flow %
-1.66%
Top 10 Hldgs %
32.06%
Holding
404
New
37
Increased
55
Reduced
144
Closed
19

Top Buys

Rank Stock Value
1
CG icon
Carlyle Group
CG
+$35.2M
2
MTDR icon
Matador Resources
MTDR
+$10.3M
3
DNOW icon
DNOW Inc
DNOW
+$9.86M
4
BBBY
Bed Bath & Beyond Inc
BBBY
+$7.17M
5
APD icon
Air Products & Chemicals
APD
+$4.82M

Top Sells

Rank Stock Value
1
TPR icon
Tapestry
TPR
+$45.4M
2
SLB icon
SLB Ltd
SLB
+$13.1M
3
NOV icon
NOV
NOV
+$9.35M
4
AXS icon
AXIS Capital
AXS
+$6.1M
5
IBM icon
IBM
IBM
+$5.75M

Sector Composition

Rank Sector Weight
1 Financials 23.98%
2 Energy 16.06%
3 Healthcare 14.41%
4 Technology 11.1%
5 Industrials 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMX icon
276
America Movil
AMX
$74.6B
$232K 0.01%
11,200
– –
XLF icon
277
State Street Financial Select Sector SPDR ETF
XLF
$56.5B
$232K 0.01%
11,644
-1,253
-10% -$24.4K
IJJ icon
278
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.83B
$228K 0.01%
3,600
– –
BDX icon
279
Becton Dickinson
BDX
$46.4B
$225K 0.01%
1,948
– –
ESS icon
280
Essex Property Trust
ESS
$19.1B
$223K 0.01%
+1,204
New +$213K
BXE
281
DELISTED
Bellatrix Exploration Ltd.
BXE
$218K ﹤0.01%
5,000
– –
PSX icon
282
Phillips 66
PSX
$82.9B
$217K ﹤0.01%
2,700
-200
-7% -$16.5K
EW icon
283
Edwards Lifesciences
EW
$49.4B
$216K ﹤0.01%
+15,120
New +$205K
ATI icon
284
ATI
ATI
$24.3B
$214K ﹤0.01%
+4,739
New +$194K
DMLP icon
285
Dorchester Minerals
DMLP
$1.3B
$214K ﹤0.01%
+7,000
New +$196K
PH icon
286
Parker-Hannifin
PH
$120B
$213K ﹤0.01%
1,694
-147
-8% -$18.3K
AFL icon
287
Aflac
AFL
$65.5B
$211K ﹤0.01%
6,768
+350
+5% +$10.9K
ARW icon
288
Arrow Electronics
ARW
$10.5B
$211K ﹤0.01%
3,500
– –
ETV
289
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.66B
$209K ﹤0.01%
+14,197
New +$208K
IFF icon
290
International Flavors & Fragrances
IFF
$20.3B
$209K ﹤0.01%
2,000
-438
-18% -$43.1K
VYNT
291
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$208K ﹤0.01%
123
– –
DGX icon
292
Quest Diagnostics
DGX
$26B
$205K ﹤0.01%
3,494
– –
EWT icon
293
iShares MSCI Taiwan ETF
EWT
$9.13B
$202K ﹤0.01%
6,378
– –
BAC icon
294
Bank of America
BAC
$429B
$173K ﹤0.01%
11,246
– –
EOI
295
Eaton Vance Enhanced Equity Income Fund
EOI
$789M
$172K ﹤0.01%
+12,479
New +$166K
GIC icon
296
Global Industrial
GIC
$1.38B
$148K ﹤0.01%
10,300
– –
KEY icon
297
KeyCorp
KEY
$23.8B
$143K ﹤0.01%
10,000
– –
MCN
298
Madison Covered Call & Equity Strategy Fund
MCN
$117M
$93K ﹤0.01%
+10,595
New +$90K
DSU icon
299
BlackRock Debt Strategies Fund
DSU
$592M
$81K ﹤0.01%
+6,581
New +$80.9K
ZNGA
300
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$46K ﹤0.01%
+14,259
New +$51.6K
9 10 11
12
13

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q2 2014 Portfolio in Review

As of Q2 2014, Beck Mack & Oliver held 404 positions worth $4.45B, up 4.1% from $4.28B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Beck Mack & Oliver's Q2 2014 filing shows 37 new, 55 increased, 144 reduced and 19 closed positions. Its largest new stake was Carlyle Group: 1,070,406 shares worth $36.4M. The largest sale was Tapestry, an estimated $45.4M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 24% a quarter earlier, followed by Energy and Healthcare.

  • Beck Mack & Oliver's largest Q2 2014 buy was Carlyle Group: 1,070,406 shares worth $36.4M.
  • Beck Mack & Oliver added most to Matador Resources in Q2 2014, an estimated $10.3M increase.
  • Beck Mack & Oliver's biggest Q2 2014 reduction was SLB Ltd, cutting an estimated $13.1M.
  • Beck Mack & Oliver fully exited Tapestry in Q2 2014, selling an estimated $45.4M.
  • Beck Mack & Oliver's ten largest holdings make up 32% of its $4.45B portfolio in Q2 2014.
  • Beck Mack & Oliver opened 37 new positions and closed 19 in Q2 2014.
  • Beck Mack & Oliver's portfolio value rose 4.1% quarter-over-quarter to $4.45B.

Based on Beck Mack & Oliver's 13F filing for Q2 2014, filed 31 Jul 2014.